Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Revenue minus cost of goods sold
3Y CAGR
+75.0%/yr
vs -28.4%/yr prior
5Y CAGR
+2.9%/yr
Recent acceleration
Acceleration
+103.3pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $259.78M | -1.5% |
| 2024 | $263.71M | +260.9% |
| 2023 | $73.07M | +50.6% |
| 2022 | $48.51M | -24.5% |
| 2021 | $64.23M | -71.5% |
| 2020 | $225.16M | +51.8% |
| 2019 | $148.36M | -19.5% |
| 2018 | $184.21M | +71498.8% |
| 2017 | $-258000.00 | -2.4% |
| 2016 | $-252000.00 | - |